Edelman, a global communications and marketing company, has named Alan Maine as its new senior director, it was reported yesterday.
Maine has earlier served as head of policy and public affairs at Pfizer UK, where he was responsible for government affairs and market access policy development activity, covering both corporate and therapy area public affairs. During his time at Pfizer, Maine also worked with industry associations on campaigns, policies and initiatives relating to access to medicines. Prior to his time with Pfizer, Maine was head of government affairs at Wyeth Pharmaceuticals, later acquired by Pfizer, and has held other roles with Merck Sharpe & Dohme.
Kate Hawker, managing director for Edelman UK, said, 'We are very excited about Alan joining Edelman as he brings with him such great knowledge and insight of the complex challenges in the UK.'
AbbVie's Allergan Aesthetics announces Natrelle supplier agreement with Vizient
Karyopharm Therapeutics awards inducement grants to new employees
POLYTECH Health & Aesthetics announces Poland expansion
Santhera Pharmaceuticals signs Gulf region distribution agreement with Uniphar
Novo Nordisk expands legal action over compounded 'semaglutide'
Neuraxpharm launches Neuraxpharm Australia
OncoZenge selects Meribel Pharma as CDMO for Phase 3 BupiZenge project
Fridays nominated for World Out of Home awards for weight loss campaign
Physiomics expands into biometrics with two contract wins and new division head